Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00806715 · ClinicalTrials.gov registry record

Iron Overload in Stem Cell Transplant Recipients

A clinical trial, sponsored by Boston Children's Hospital.

Completed
Registry status
38
Enrollment target

NCT00806715 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00806715 has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
38 participants
Enrollment target

Study Summary

The goal of this study is to examine the impact of iron overload in patients undergoing a bone marrow transplant. We believe that the iron status in these patients is associated with complications for transplant survivors. We will examine the iron status in these patients by MRI and by screening for mutations in genes known to cause iron overload. We will also determine the levels of hepcidin (a hormone produced in the liver that appears to regulate iron homeostasis) from blood and urine.

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2007-02
Est. Completion 2010-10

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT00806715

The ClinicalTrials.gov registry entry for NCT00806715 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00806715 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00806715 about?

NCT00806715 is a clinical study titled "Iron Overload in Stem Cell Transplant Recipients". The goal of this study is to examine the impact of iron overload in patients undergoing a bone marrow transplant. We believe that the iron status in these patients is associated with complications for transplant survivors. We will examine the iron status in these patients by MRI and by screening for...

What is the current status of trial NCT00806715?

This trial is currently completed. The enrollment target is 38 participants. The study started on 2007-02. Estimated completion is 2010-10.

Who is sponsoring clinical trial NCT00806715?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.